Kinetic Concepts, Inc (KCI) has reached an agreement to license Wright Medical Group's GraftJacket brand, to market the LifeCell acellular human dermal-based regenerative tissue matrix for wound applications such as diabetic foot ulcers and venous stasis ulcers.

KCI’s Active Healing Solutions business unit uses GraftJacket brand name to sell LifeCell regenerative tissue matrix in outpatient wound care clinics, physicians’ offices, or as a hospital inpatient.

With the addition of GraftJacket Matrix KCI offers both negative pressure wound therapy (NPWT) and regenerative tissue matrix by treating hard-to-heal wounds and helps clinicians to treat wounded patients with two modalities.

GraftJacket Matrix acts as a scaffold allowing the body to convert the matrix to functional host tissue in ulcer repair.

KCI Active Healing Solutions global president Mike Genau said regenerative medicine plays a role in the practice of wound healing, and KCI stands at the forefront of that breakthrough.

"By bringing GraftJacket Matrix to the clinical community for the repair of challenging chronic wounds such as diabetic foot ulcers, KCI is responding to the physician’s need to customize treatment options for patients’ individual wounds," Genau said.